MILAN, ITALY – Amplifon S.p.A., a global leader in hearing care solutions and services, announced consolidated revenues of €2.4 billion (approximately $2.6 billion USD) for fiscal year 2025, marking a 1.7% increase at constant exchange rates compared to the previous year. Despite a challenging global economic landscape that saw overall market expansion remain below historical averages, the company demonstrated strategic agility, achieving improving organic growth in the latter half of the year. This performance underscores Amplifon’s ability to adapt and execute critical initiatives designed to bolster profitability and lay a robust foundation for future expansion amidst persistent market headwinds.
Fiscal Year 2025 Financial Highlights
The Milan-headquartered firm reported an adjusted EBITDA of €540.4 million (approximately $583 million USD), translating to a healthy margin of 22.6%. This figure reflects effective cost management and operational streamlining undertaken throughout the year. Adjusted net profit for the fiscal year reached €159.2 million (approximately $172 million USD). In a testament to its commitment to shareholder returns, Amplifon’s Board of Directors has proposed a dividend of €0.29 per share, signaling confidence in the company’s financial health and future prospects, even as it navigated a complex operating environment.
Beyond top-line revenue and profitability, Amplifon’s financial strength was further evidenced by an adjusted free cash flow of €174.4 million (approximately $188 million USD) for the year. This robust cash generation is crucial for funding ongoing operations, strategic investments, and shareholder distributions. However, net financial debt saw an increase, standing at €1.05 billion (approximately $1.13 billion USD) at the close of 2025, up from €961.8 million (approximately $1.04 billion USD) at the end of 2024. This rise in debt is attributed to significant capital expenditures, targeted acquisitions, dividend payments, and share buybacks, collectively exceeding €350 million (approximately $378 million USD) over the year. These investments reflect Amplifon’s long-term growth strategy, balancing immediate profitability with strategic expansion.
Navigating a Complex Market Landscape
The year 2025 was characterized by softer market conditions across the entire hearing care sector. Global economic uncertainty, marked by inflationary pressures, fluctuating interest rates, and geopolitical tensions, significantly impacted consumer confidence and discretionary spending. This broader macroeconomic environment directly influenced the demand for hearing care services and products, leading to an industry-wide growth slowdown compared to pre-pandemic levels.
In response to these formidable challenges, Amplifon proactively implemented a series of operational and strategic initiatives aimed at reinforcing its market position, enhancing profitability, and fostering sustainable growth. These actions were multifaceted, encompassing both aggressive expansion in key markets and a rigorous efficiency-driven restructuring program. The strategic playbook included the continued expansion of the Miracle-Ear direct network in the United States, a critical market for the company, alongside targeted acquisitions in high-potential geographies such as France, Germany, Poland, the United States, and China. These acquisitions are vital for increasing market share and leveraging economies of scale.
The "Fit4Growth" Efficiency Program Takes Center Stage
A cornerstone of Amplifon’s strategic response to the challenging market was the acceleration and intensified implementation of its "Fit4Growth" efficiency program. This comprehensive initiative was designed to streamline operations, optimize the company’s global footprint, and significantly enhance profitability. The program entailed several decisive actions:
- Network Optimization: The closure of approximately 160 clinics across 10 countries was a strategic move to divest underperforming assets and consolidate resources in more profitable locations. This rationalization ensures that Amplifon’s vast network of thousands of points of sale globally operates at peak efficiency.
- Operational Streamlining: The Fit4Growth program also targeted operational efficiencies in back-office functions, aiming to reduce administrative overheads and improve overall organizational agility.
- Capital Expenditure Rationalization: A disciplined approach to capital expenditures resulted in reduced spending compared to 2024, reflecting a focus on maximizing returns from existing assets and prioritizing essential investments.
- Strategic Divestment: As part of the program, Amplifon strategically divested its business in the United Kingdom. This decision aligns with the broader objective of focusing resources on core markets and optimizing portfolio performance.
The Fit4Growth program, while involving significant restructuring, is anticipated to deliver substantial long-term benefits, recalibrating Amplifon’s cost structure and improving its competitive edge.
Regional Performance Analysis: A Mixed but Resilient Picture
Amplifon’s total consolidated revenues of €2,395.7 million (approximately $2.6 billion USD) were bolstered by strategic acquisitions, which contributed approximately 1.7% to the overall revenue performance. However, currency movements exerted a negative impact on reported results, leading to revenues at current exchange rates remaining broadly stable compared to 2024.
A regional breakdown reveals varying performance trajectories:
- EMEA (Europe, Middle East, and Africa): This region reported revenue increases, largely supported by an improved organic performance during the second half of the year. This recovery indicates that strategic initiatives and market adaptations began to yield positive results as the year progressed, mitigating earlier market softness.
- Americas: The company noted above-market organic growth in the Americas, despite a challenging comparison base from the previous year. This performance highlights the effectiveness of the Miracle-Ear direct network expansion and Amplifon’s strong brand presence in the region, outperforming broader market trends.
- Asia-Pacific: This region experienced softer results overall. Underlying market weakness, potentially exacerbated by specific economic conditions in certain countries, combined with the restructuring activities associated with the Fit4Growth program, contributed to a more subdued performance. The impact of these restructuring efforts, while necessary for long-term health, temporarily affected short-term regional growth.
Fourth Quarter 2025: Signs of Momentum
The final quarter of 2025 offered further evidence of Amplifon’s improving trajectory. For the fourth quarter alone, Amplifon reported revenues of €651.9 million (approximately $704 million USD), representing a growth of 1.4% at constant exchange rates compared to the same period in 2024.
Adjusted EBITDA for the quarter stood at €145.5 million (approximately $157 million USD), yielding a margin of 22.3%. While this was slightly down from €154.4 million (approximately $167 million USD) in the fourth quarter of the previous year, it reflects the ongoing investments and restructuring costs associated with the Fit4Growth program, which are expected to pay dividends in subsequent periods. Adjusted net profit for the quarter was €49.5 million (approximately $53 million USD). The Q4 results, particularly the return to organic growth, underscored the positive impact of the strategic initiatives implemented throughout the year.
Leadership Perspective and Forward-Looking Confidence
Enrico Vita, Amplifon’s CEO, acknowledged the challenging market conditions of 2025 but emphasized the company’s improving performance trends. In his commentary on the results, Vita stated, "2025 was a challenging year for the hearing care industry as a whole with growth below historic levels, above all due to the well-known global tensions which affected our patients’ confidence. In this context, we implemented a series of actions to accelerate revenues and improve profitability, which are already generating very positive results. These include the return to organic growth in the second half of the year and the acceleration in the ‘Fit4Growth’ performance improvement program. These initiatives, in a market which we expect will gradually improve, allow us to look at the prospects for our business with renewed confidence."
Vita’s statement highlights a critical turning point for Amplifon: the successful pivot to organic growth in the latter half of the year, demonstrating the effectiveness of its strategic interventions. The acceleration of the Fit4Growth program, even amidst a soft market, is a testament to the company’s proactive management and commitment to long-term efficiency.
Outlook for 2026: Enhanced Profitability and Growth Trajectory
Looking ahead, Amplifon’s leadership expresses a renewed sense of optimism for 2026. The company anticipates a progressive improvement in organic growth throughout the year compared to 2025. This projection is underpinned by an expectation of gradually improving market conditions, coupled with the continued positive impact of its strategic initiatives.
Furthermore, Amplifon foresees a meaningful increase in its adjusted EBITDA margin as the Fit4Growth program continues to deliver operational efficiencies and cost savings. The company has indicated that by 2027, the margin improvement is now expected to reach the higher end of the program’s originally announced target range of +150 to 200 basis points. This upward revision of the margin target signals strong confidence in the program’s ability to drive significant and sustainable profitability enhancements, placing Amplifon in an even stronger competitive position. This commitment to efficiency and profitability, combined with a focus on strategic expansion, positions Amplifon to capitalize on the underlying growth drivers of the global hearing care market, such as aging populations and increasing awareness of hearing health.
Broader Implications for the Hearing Care Sector
Amplifon’s 2025 performance and 2026 outlook offer valuable insights into the broader hearing care sector. The year demonstrated that even a resilient industry, driven by demographic trends, is not immune to macroeconomic pressures affecting consumer discretion. However, Amplifon’s strategic response – combining aggressive network expansion and targeted acquisitions with a rigorous efficiency program – provides a blueprint for navigating such complexities. The focus on profitability and operational excellence, alongside a continued commitment to market leadership, will likely define success in the evolving hearing care landscape. As the industry continues to innovate, particularly with advancements in technology and changing regulatory environments (such as the emergence of over-the-counter hearing aids in some markets), Amplifon’s adaptable strategy and strong financial footing position it favorably to maintain its global leadership.
In conclusion, Amplifon’s fiscal year 2025 results reflect a company that effectively navigated a challenging period through decisive strategic actions and operational discipline. The return to organic growth in the second half of the year and the accelerated impact of the Fit4Growth program underscore its resilience. With an optimistic outlook for 2026, driven by anticipated market improvements and enhanced profitability targets, Amplifon appears well-prepared to strengthen its global leadership in hearing care solutions.
About Amplifon
Amplifon is a global leader in hearing care solutions and services. Founded in 1950 and headquartered in Milan, Italy, the company operates through an extensive network of hearing care clinics and retail locations across multiple continents, including North America, Europe, and Asia-Pacific. Amplifon provides comprehensive hearing testing, a wide range of advanced hearing aids, and related services, serving millions of customers worldwide through thousands of points of sale. The company continues to expand its global presence through a combination of organic growth, strategic acquisitions, and continuous network development, striving to improve the quality of life for individuals with hearing impairments.
Source: Amplifon